3billion makes genetic test for rare diseases affordable
- News | 20. 05. 11
3billion announces that for a service fee of $699, it can diagnose over 7,000 rare diseases by examining patients’ genetic data. The company has over 4,000 actual diagnosis results and is expected to exceed 10,000 diagnoses this year.
3billion CEO Changwon Keum said:
By adding proprietary, streamlined interpretation software, we can analyze 100,000+ variants in a minute. The interpretation software has made it possible to reduce costs and time spent on the interpretation step, thereby making the test more affordable.
Keum also mentioned that the global market size would reach 7 to 8 trillion won by 2025, given that 8 percent of the world’s population suffers from rare genetic diseases. The current boom in the genetic testing service market is also responsible for this development.
Do you find this post helpful?
Click the button below to copy and share the link.
3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.
